Cargando…

Efficacy of Mass Azithromycin Distribution for Reducing Childhood Mortality Across Geographic Regions

Mass azithromycin distribution has been shown to reduce all-cause mortality in preschool children in sub-Saharan Africa. However, substantial heterogeneity in the apparent effect has been noted across geographic settings, suggesting a greater relative benefit in higher mortality settings. Here, we e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Porco, Travis C., Oldenburg, Catherine E., Arzika, Ahmed M., Kalua, Khumbo, Mrango, Zakayo, Cook, Catherine, Lebas, Elodie, Bailey, Robin L., West, Sheila K., Oron, Assaf P., Keenan, Jeremy D., Lietman, Thomas M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470520/ https://www.ncbi.nlm.nih.gov/pubmed/30734695 http://dx.doi.org/10.4269/ajtmh.18-1003

Ejemplares similares

Effect Modification by Baseline Mortality in the MORDOR Azithromycin Trial
por: Oron, Assaf P., et al.
Publicado: (2020)

Mass azithromycin distribution for reducing childhood mortality in sub-Saharan Africa
por: Keenan, Jeremy D, et al.
Publicado: (2018)

Mass Azithromycin Distribution to Prevent Childhood Mortality: A Pooled Analysis of Cluster-Randomized Trials
por: Oldenburg, Catherine E., et al.
Publicado: (2019)

Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial
por: Porco, Travis C, et al.
Publicado: (2019)

Effect of Mass Azithromycin Distributions on Childhood Growth in Niger: A Cluster-Randomized Trial
por: Arzika, Ahmed M., et al.
Publicado: (2021)

Safety of azithromycin in infants under six months of age in Niger: A community randomized trial
por: Oldenburg, Catherine E., et al.
Publicado: (2018)

MORDOR II: Persistence of Benefit of Azithromycin for Childhood Mortality
por: Keenan, Jeremy D., et al.
Publicado: (2019)

Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger
por: O’Brien, Kieran S., et al.
Publicado: (2020)

Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial
por: Arzika, Ahmed M., et al.
Publicado: (2019)

Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial
por: Keenan, Jeremy D, et al.
Publicado: (2020)

Selection of Macrolide and Non-Macrolide Resistance with Mass Azithromycin Distribution: A Community-Randomized Trial
por: Doan, Thuy, et al.
Publicado: (2020)

Causes of death after biannual azithromycin treatment: A community-level randomized clinical trial
por: Bloch, Evan M., et al.
Publicado: (2021)

Anthropometric Differences in Community- Versus Clinic-Recruited Infants Participating in a Trial of Azithromycin for Prevention of Childhood Mortality in Burkina Faso
por: Ouattara, Mamadou, et al.
Publicado: (2023)

Biannual Treatment of Preschool Children with Single Dose Azithromycin to Reduce Mortality: Impact on Azithromycin Resistance in the MORDOR Trial in Tanzania
por: Bloch, Evan M., et al.
Publicado: (2020)

Impact of Biannual Azithromycin on Anemia in Preschool Children in Kilosa District, Tanzania: A Cluster-Randomized Clinical Trial
por: Bloch, Evan M., et al.
Publicado: (2020)

Malaria Parasitemia and Nutritional Status during the Low Transmission Season in the Presence of Azithromycin Distribution among Preschool Children in Niger
por: Arzika, Ahmed M., et al.
Publicado: (2020)

Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma
por: Amza, Abdou, et al.
Publicado: (2021)

Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger
por: Arzika, Ahmed M., et al.
Publicado: (2022)

Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger
por: Hazel, Ashley, et al.
Publicado: (2023)

Effect of Mass Treatment with Azithromycin on Causes of Death in Children in Malawi: Secondary Analysis from the MORDOR Trial
por: Hart, John D., et al.
Publicado: (2020)

Cost-Effectiveness of Mass Treatment with Azithromycin for Reducing Child Mortality in Malawi: Secondary Analysis from the MORDOR Trial
por: Hart, John D., et al.
Publicado: (2020)

Gut Resistome of Preschool Children After Prolonged Mass Azithromycin Distribution: A Cluster-randomized Trial
por: Arzika, Ahmed M, et al.
Publicado: (2021)

Neonatal azithromycin administration for prevention of infant mortality
por: Oldenburg, Catherine E., et al.
Publicado: (2022)

Indirect Effect of Azithromycin Use on the Intestinal Microbiome Diversity of Untreated Children: A Randomized Trial
por: Oldenburg, Catherine E, et al.
Publicado: (2019)

Optimizing the Number of Child Deaths Averted with Mass Azithromycin Distribution
por: Oldenburg, Catherine E., et al.
Publicado: (2020)

Effect of Single-dose Azithromycin on Pneumococcal Carriage and Resistance: A Randomized Controlled Trial
por: Coulibaly, Boubacar, et al.
Publicado: (2022)

Reduction of Coronavirus Burden With Mass Azithromycin Distribution
por: Doan, Thuy, et al.
Publicado: (2020)

A double-masked placebo-controlled trial of azithromycin to prevent child mortality in Burkina Faso, West Africa: Community Health with Azithromycin Trial (CHAT) study protocol
por: Sié, Ali, et al.
Publicado: (2019)

The impact on malaria of biannual treatment with azithromycin in children age less than 5 years: a prospective study
por: Bloch, Evan M., et al.
Publicado: (2019)

Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR)
por: O’Brien, Kieran S., et al.
Publicado: (2021)

Effects of Biannual Azithromycin Mass Drug Administration on Malaria in Malawian Children: A Cluster-Randomized Trial
por: Hart, John D., et al.
Publicado: (2020)

Neonatal azithromycin administration to prevent infant mortality: study protocol for a randomised controlled trial
por: Sie, Ali, et al.
Publicado: (2019)

Single-dose azithromycin for child growth in Burkina Faso: a randomized controlled trial
por: Sié, Ali, et al.
Publicado: (2021)

Neonatal Azithromycin Administration and Growth during Infancy: A Randomized Controlled Trial
por: Sie, Ali, et al.
Publicado: (2023)

Mass Azithromycin Distribution and Community Microbiome: A Cluster-Randomized Trial
por: Doan, Thuy, et al.
Publicado: (2018)

Effect of Biannual Mass Azithromycin Distributions to Preschool-Aged Children on Trachoma Prevalence in Niger: A Cluster Randomized Clinical Trial
por: Arzika, Ahmed M., et al.
Publicado: (2022)

Effect of a single dose of oral azithromycin on malaria parasitaemia in children: a randomized controlled trial
por: Coulibaly, Boubacar, et al.
Publicado: (2021)

Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial
por: Oldenburg, Catherine E., et al.
Publicado: (2019)

Adverse Events and Clinic Visits following a Single Dose of Oral Azithromycin among Preschool Children: A Randomized Placebo-Controlled Trial
por: Sié, Ali, et al.
Publicado: (2021)

A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma
por: West, Sheila K., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_e409ohl6bo30mv08fvf0mrtmsd